Athira Pharma Inc.
DOJ
False Claims Act
Penalty
$4.1 million
Outcome
Athira Pharma Inc. Agrees to Pay $4M to Settle False Claims Act Allegations Related to Scientific Research Misconduct
Details
Athira Pharma Inc. — DOJ Enforcement (2025)
DOJ took enforcement action against Athira Pharma Inc. in WA in 2025 involving false claims act violations in the Independent Pharmacies sector.
Penalty: $4.1 million
Violation types: False Claims Act
Entity type: Pharmacy
Penalty type: Settlement
Location: WA
Source: DOJ Press Release — Athira Pharma Inc. Agrees to Pay $4M to Settle False Claims Act Allegations Related to Scientific Research Misconduct
How Crucible Prevents This
Crucible's billing compliance controls enforce documentation-to-claims reconciliation and flag billing anomalies before false claims are submitted.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works